04.11.2025
... neuartige Version des von Genentech/Roche vermarkteten ADC Kadcyla® (ado-trastuzumab ...
01.11.2025
... %, Bayer -2,97%, Lanxess -4,53%, Roche GS -4,54%, Novartis -4,62%, Ibu ... 34% , BASF 0,94% , MorphoSys 0,15% , Roche GS -0,38% , Novartis -0,85% , Lanxess ...
01.11.2025
... Motor -2,63%, Zumtobel -4,24%, Roche GS -4,54%, Novartis -4,62%, Ford ... 86% , voestalpine 1,65% , Microsoft -0,03% , Roche GS -0,38% , Honda Motor -0,71 ...
27.10.2025
... (94) EUR - 'BUY' - JEFFERIES SENKT ROCHE AUF 'UNDERPERFORM' (HOLD) - ZIEL 230 ...